期刊文献+

Preparation and Evaluation in Vitro of BCNU-Loaded PLA Nanoparticles

Preparation and Evaluation in Vitro of BCNU-Loaded PLA Nanoparticles
下载PDF
导出
摘要 In this study,using a spontaneous emulsification/solvent extraction method,BCNU-loaded PLA nanoparticles (NPs) with small particle size and narrow size distribution have been acquired. The particle size of the NPs ranged from 40~60 nm and 100~200 nm according to different requirements. SEM and TEM showed that the particle size considerably decreases with increasing emulsification concentration and decreasing PLA concentration and ratio of oil to water. The highest drug loading ratio and drug encapsulation efficiency of NPs were 5.63% and 33.45%. The results demonstrated that decrease of initial BCNU content resulted in a noticeably increased encapsulation yield. A thorough study in vitro showed that the drug could be steadily released from NPs for one week. In addition,drug-loaded NPs had higher antitumor activity,compared with free BCNU,and sustained drug release characteristics as well. In this study, using a spontaneous emulsification/solvent extraction method, BCNU-Ioaded PLA nanoparticles (NPs) with small particle size and narrow size distribution have been acquired. The particle size of the NPs ranged from 40-60 nm and 100-200 nm according to different requirements. SEM and TEM showed that the particle size considerably decreases with increasing emulsification concentration and decreasing PLA concentration and ratio of oil to water. The highest drug loading ratio and drug encapsulation efficiency of NPs were 5. 63% and 33.45%. The results demonstrated that decrease of initial BCNU content resuited in a noticeably increased encapsulation yield. A thorough study in vitro showed that the drug could be steadily released from NPs for one week. In addition, drug-loaded NPs had higher antitumor activity, compared with free BCNU,and sustained drug release characteristics as well.
出处 《Chinese Journal of Biomedical Engineering(English Edition)》 2004年第3期110-117,共8页 中国生物医学工程学报(英文版)
基金 National NatureScience Foundation( No.5 0 30 10 0 8),National Key basic researchProgram( No.2 0 0 1CCC0 14 0 0 ),TianjinNatureScience Foundation( No.0 136 16 6 11)
关键词 Drug delivery system BCNU PLA NANOPARTICLE Controlled release Cancer therapy 卡氮芥 药物微粒 用药途径 药物释放 肿瘤 药物治疗
  • 相关文献

参考文献6

  • 1Eric P. Sipos,Betty Tyler,Steven Piantadosi,Peter C. Burger,H. Brem.Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors[J].Cancer Chemotherapy and Pharmacology.1997(5)
  • 2Sipos EP,Tyler B,Piantadosi S,et al.Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain rumors[].Cancer Chemother.1997
  • 3Soppimath KS,Aminabhavi TM,Kulkaroi AR,et al.Biodegradable polymeric nanoparticles as drug delivery devices, J[].Journal of Controlled Release.2001
  • 4LOO TL,Dion RL,Dixon RL,et al.The antitumor agent , 1, 3-bis (2-chloroethyl )-1-nitrosourea, J[].Journal of Pharmaceutical Sciences.1966
  • 5Painbeni T,Venier-Julienne MC,Benoit JP.Internal norphology of poly (D, L-lactide-co-glycolide ) BCNU-loaded microspheres.Influence on drug stability, Eur[].J Pharm and Biopharm.1998
  • 6Loo TL,Dion RL.Colorimetric method for the determination of 1, 3-bis(2-chloroethyl )-1-nitrosourea, J[].Journal of Pharmaceutical Sciences.1965

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部